RSE
Gauss

HTRF - Cdk2 phospho-y15 - 500 tests 1 Kit

Réf. UGAP : 3732232 Réf. Fournisseur : 64CDK2Y15PEG Réf. Constructeur : 64CDK2Y15PEG
HTRF - Cdk2 phospho-y15 - 500 tests 1 Kit
Franco de port et d'emballage pour toutes les commandes supérieures à 80€ HT.

Produit ni repris ni échangé excepté en cas d’erreur du prestataire.
La quantité choisie doit être comprise entre 1 et 999 999.

Points clés

Alternative ELISA et WB, plus simple, plus rapide, très sensible, facilement miniaturisable / automatisable et peu onéreuse.

This HTRF cell-based assay conveniently and accurately detects phosphorylated CDK2 at Tyr15. ​​​​​​​ CDK2 (Cyclin-Dependent Kinase 2) is a member of the subfamily of CDKs that coordinate cell cycle progression in mammalian cells (also including CDK1, CDK4, and CDK6). CDK2 is activated by interaction with Cyclin E and Cyclin A during the late G1 phase and S phase respectively, and is also regulated by two major phospho-sites. Phosphorylation at Tyr15 by the kinase Wee1 is inhibitory by preventing ATP binding, whereas Tyr15 dephosphorylation by the phosphatase Cdc25A and phosphorylation at Thr160 by CAK (CDK Activating Kinase) is required for its full activity. CDK2 inhibitory phosphorylation at Tyr15 is essential for maintaining genome integrity and preventing DNA damage during the S phase. The Wee1/Cdc25A axis is therefore an attractive target for cancer therapy and may represent a unique approach to sensitize cancer cells with hyperactive CDK2.

En savoir plus

Garantie

Garantie 0 Mois

Description

Alternative ELISA et WB, plus simple, plus rapide, très sensible, facilement miniaturisable / automatisable et peu onéreuse.

This HTRF cell-based assay conveniently and accurately detects phosphorylated CDK2 at Tyr15. ​​​​​​​ CDK2 (Cyclin-Dependent Kinase 2) is a member of the subfamily of CDKs that coordinate cell cycle progression in mammalian cells (also including CDK1, CDK4, and CDK6). CDK2 is activated by interaction with Cyclin E and Cyclin A during the late G1 phase and S phase respectively, and is also regulated by two major phospho-sites. Phosphorylation at Tyr15 by the kinase Wee1 is inhibitory by preventing ATP binding, whereas Tyr15 dephosphorylation by the phosphatase Cdc25A and phosphorylation at Thr160 by CAK (CDK Activating Kinase) is required for its full activity. CDK2 inhibitory phosphorylation at Tyr15 is essential for maintaining genome integrity and preventing DNA damage during the S phase. The Wee1/Cdc25A axis is therefore an attractive target for cancer therapy and may represent a unique approach to sensitize cancer cells with hyperactive CDK2.

Caractéristiques

Marque
REVVITY
Libellé produit fabricant
Phospho-CDK2 (Tyr15) Cellular Kit, 500 Tests
Référence distributeur
64CDK2Y15PEG
Référence fabricant
64CDK2Y15PEG
Fournisseur
REVVITY
Reprise en cas d’erreur client
non
Lieu de fabrication
France
Lieu de stockage
France
Domaine de recherche
biologie cellulaire
Délai de péremption à la date de livraison
6 mois
Soumis à réglementation
non
Température de conservation (°C)
-80 à -60 °C
Type d’application
PhosphoELISA
Vendu par
1 kit
Quantité
N/A
Nomenclature Nacres
NA.84
Nomenclature IFPEN
NA.84
Nomenclature CEA
SGP01
Nomenclature IRSN
273
Nomenclature INSERM
NA.NA84
Nomenclature CNRS
NA84
Nomenclature CHU
18.551
Nomenclature DGOS
LD11AOOO
Type d'échantillon
sérum, plasma, surnageant de culture cellulaire, tissu
Certification
RUO